425 results on '"Eclache, Virginie"'
Search Results
102. Impact of Cytogenetics and Cytogenetic Response On Outcome in MDS Treated with Azacitidine (AZA).
103. Incidence of 17p deletions and TP53 mutation in myelodysplastic syndrome and acute myeloid leukemia with 5q deletion
104. 2.55 CLL Cell Survival Depends on B Cell Receptor Signaling-Induced NFAT2 Activation
105. Hypomethylating agents reactivate FOXO3A in acute myeloid leukemia
106. Le caryotype fait mieux que la FISH pour suivre les MDS avec del(5q) traitées par lénalidomide
107. Deletion of the Tumor Suppressor Gene NF1 Is Found In 3.5% of 485 De Novo Adult Myeloid Leukemia and Is Correlated with Unfavourable Cytogenetic: On Behalf of the ALFA Group
108. Risk of AML Evolution In Lower Risk MDS with Del 5q Treated with or without Lenalidomide. A Report by the Groupe Francophone Des Myelodysplasies (GFM)
109. Will a Peripheral Blood (PB) Sample Yield the Same Diagnostic and Prognostic Cytogenetic Data as the Concomitant Bone Marrow (BM) In Myelodysplasia? An International Study Comparing Cytogenetics and Interphase FISH Using Parallel PB and BM Samples
110. Unrelated Clones In Myelodysplastic Syndromes and Acute Myeloid Leukemia - Characterization and Prognostic Relevance
111. High Body Mass Index (BMI) as a Predictor of Differentiation Syndrome (DS) In Acute Promyelocytic Leukemia (APL).
112. Specific Chromosomal IG Translocations Have Different Prognosis In Chronic Lymphocytic Leukemia
113. Cytogenetic Abnormalities In a Cohort of 171 Patients with Waldenström Macroglobulinemia Before Treatment: Clinical and Biological Correlations
114. SNP-Arrays: a Routine Cytogenetic Tool In Chronic Lymphocytic Leukemia ?.
115. Chromosomal abnormalities in transformed Ph‐negative myeloproliferative neoplasms are associated to the transformation subtype and independent of JAK2 and the TET2 mutations
116. Detection of 13q14 Deletion by FISH Is Not Sufficient to Define a Group of Good Prognosis Patients with Chronic Lymphocytic Leukemia.
117. Chromosomal Abnormalities in Transformed Ph-Negative Myeloproliferative Neoplasm Are Independent of the JAK2 and the TET2 Statuses.
118. Antiphospholipid syndrome during acute monocytic leukaemia
119. Combined translocation with ZNF198-FGFR1 gene fusion and deletion of potential tumor suppressors in a myeloproliferative disorder
120. Randomized Comparison of Imatinib Versus Imatinib Combination Therapies in Newly Diagnosed Chronic Myeloid Leukaemia (CML) Patients in Chronic Phase (CP): First Results of the Phase III (SPIRIT) Trial from the French CML Group (FI LMC)
121. Deletions of Chromosomes 6q and 13q, and Trisomy 4 Are the Most Common Cytogenetic Abnormalities in Waldenstrom Macroglobulinemia. Preliminary Results of a Multicentric Study.
122. Characteristics and Outcome of MDS with Isolated Del 20q: The GFM Experience in 64 Cases.
123. Treatment of Lower Risk MDS with Del 5q by Lenalidomide, with or without G-CSF: Current Results of the French Patient Named Program (ATU)
124. Loss of the Y Chromosome in Philadelphia-Positive Cells Predicts a Poor Response of CML Patients to Imatinib Mesylate Therapy.
125. Prognostic Impact of Additional Chromosomal Aberrations (ACA) to 5q- in Patients with primary Myelodysplastic Syndrome.
126. Evaluation of Minimal Residual Disease Based on NPM1 Mutations in AML with Intermediate Risk Cytogenetics: A Prospective Study of 36 Patients.
127. Prognostic Impact of Cytogenetic Abnormalities in Elderly Patients with Acute Myeloid Leukemia (AML) Enrolled in the ALFA-9803 Trial.
128. Correlations between BCR-ABL Ratio and Cytogenetic Response at Months 12 of the Randomized French SPIRIT Study on Behalf the Fi-LMC Group.
129. Analysis of B-CLL with Discordant ZAP-70 Expression and IgVH Mutational Status.
130. Atypical BCR-ABL Transcripts Chronic Myelogenous Leukemias Show Particular Features, and Their Classical Worse Prognosis Seems Abrogated by Imatinib Mesylate. A Retrospective Analysis of 22 Patients, on the Behalf of the French Intergroup of CML (Fi(ϕ)-LMC Group).
131. A new variant t(6;15;17)(q25;q22;q21) in acute promyelocytic leukemia: fluorescence in situ hybridization confirmation
132. Pica and food craving in patients with iron-deficiency anemia: A case-control study in France
133. Cryptic deletion involving the ATM locus at 11q22.3∼q23.1 in B-cell chronic lymphocytic leukemia and related disorders
134. A constitutional translocation t(1;4)(p21;p15) in a case of chronic lymphocytic leukemia
135. PML/RARα rearrangement in acute promyelocytic leukaemia with t(1;17) elucidated using fluorescence in situ hybridization
136. Complete nucleotide sequence of ig v genes in three cases of burkitt lymphoma associated with AIDS
137. Caractérisation moléculaire des hémopathies secondaires à une leucémie aiguë myélocytaire.
138. Characterizing Specificities of Chronic Lymphoid Leukemia Harboring a BCL2rearrangement
139. The degree of BCR and NFAT activation predicts clinical outcomes in chronic lymphocytic leukemia
140. Some characteristics of human red blood cells separated according to their size: A comparison with density-fractionated red blood cells.
141. Treatment of progression of Philadelphia-negative myeloproliferative neoplasms to myelodysplastic syndrome or acute myeloid leukemia by azacitidine: a report on 54 cases on the behalf of the Groupe Francophone des Myelodysplasies (GFM)
142. Wide diversity of PAX5 alterations in B-ALL: a Groupe Francophone de Cytogénétique Hématologique study
143. Wide diversity of PAX5alterations in B-ALL: a Groupe Francophone de Cytogénétique Hématologique study
144. Characterisation of a New Clinical Presentation of Chronic Lymphocytic Leukemia with Symptomatic Nasopharyngeal Mucosa Involvement
145. Impact du caryotype et des mutations sur la survie des leucémies aiguës myéloblastiques des patients âgés traités par 5-azacytidine ou traitement conventionnel.
146. M0 AML, clinical and biologic features of the disease, includingAML1gene mutations: a report of 59 cases by the Groupe Français d'Hématologie Cellulaire (GFHC) and the Groupe Français de Cytogénétique Hématologique (GFCH)
147. CD4+, CD56+DC2 acute leukemia is characterized by recurrent clonal chromosomal changes affecting 6 major targets: a study of 21 cases by the Groupe Français de Cytogénétique Hématologique
148. Supérioritédu ponatinib sur l'allogreffe dans les leucémies aiguës positives pour le Philadelphie avec mutation T315I.
149. The CADM1 tumor suppressor gene is a major candidate gene in MDS with deletion of the long arm of chromosome 11
150. Does red blood cell size correlate with red blood cell age in mouse?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.